Nomura Asset Management CO LTD Acadia Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

14 transactions

Quarter	Operation	Price Per share	shares change
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $0 - $0	0 New
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $0 - $0	0 Closed
Q2 2021 Aug 06, 2021	BUY	$19.4 - $27.42 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $0 - $0	0 New
Q2 2018 Aug 03, 2018	SELL	$15.07 - $22.34 $0 - $0	0 Closed
Q1 2018 May 14, 2018	BUY	$22.47 - $32.33 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $0 - $0	0 New
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $0 - $0	0

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.